These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32037904)

  • 1. Aspartic peptidase of
    Granato MQ; Sousa IS; Rosa TLSA; Gonçalves DS; Seabra SH; Alviano DS; Pessolani MCV; Santos ALS; Kneipp LF
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):629-638. PubMed ID: 32037904
    [No Abstract]   [Full Text] [Related]  

  • 2. Decoding the anti-Trypanosoma cruzi action of HIV peptidase inhibitors using epimastigotes as a model.
    Sangenito LS; Menna-Barreto RF; D Avila-Levy CM; Santos AL; Branquinha MH
    PLoS One; 2014; 9(12):e113957. PubMed ID: 25464510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,10-phenanthroline inhibits the metallopeptidase secreted by Phialophora verrucosa and modulates its growth, morphology and differentiation.
    Granato MQ; Massapust Pde A; Rozental S; Alviano CS; dos Santos AL; Kneipp LF
    Mycopathologia; 2015 Apr; 179(3-4):231-42. PubMed ID: 25502596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartic peptidases of human pathogenic trypanosomatids: perspectives and trends for chemotherapy.
    Santos LO; Garcia-Gomes AS; Catanho M; Sodre CL; Santos AL; Branquinha MH; d'Avila-Levy CM
    Curr Med Chem; 2013; 20(25):3116-33. PubMed ID: 23298141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRL-0519, a novel oxatricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor (PI), potently suppresses replication of a wide spectrum of multi-PI-resistant HIV-1 variants in vitro.
    Amano M; Tojo Y; Salcedo-Gómez PM; Campbell JR; Das D; Aoki M; Xu CX; Rao KV; Ghosh AK; Mitsuya H
    Antimicrob Agents Chemother; 2013 May; 57(5):2036-46. PubMed ID: 23403426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of HIV peptidase inhibitors on Fonsecaea pedrosoi: promising compounds to arrest key fungal biological processes and virulence.
    Palmeira VF; Kneipp LF; Rozental S; Alviano CS; Santos AL
    PLoS One; 2008; 3(10):e3382. PubMed ID: 18852883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
    Cvetkovic RS; Goa KL
    Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV protease inhibitors elicit volume-sensitive Cl- current in cardiac myocytes via mitochondrial ROS.
    Deng W; Baki L; Yin J; Zhou H; Baumgarten CM
    J Mol Cell Cardiol; 2010 Nov; 49(5):746-52. PubMed ID: 20736017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers.
    Lee GA; Rao M; Mulligan K; Lo JC; Aweeka F; Schwarz JM; Schambelan M; Grunfeld C
    AIDS; 2007 Oct; 21(16):2183-90. PubMed ID: 18090045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Select HIV protease inhibitors alter bone and fat metabolism ex vivo.
    Jain RG; Lenhard JM
    J Biol Chem; 2002 May; 277(22):19247-50. PubMed ID: 11937496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV protease inhibitors induce endoplasmic reticulum stress and disrupt barrier integrity in intestinal epithelial cells.
    Wu X; Sun L; Zha W; Studer E; Gurley E; Chen L; Wang X; Hylemon PB; Pandak WM; Sanyal AJ; Zhang L; Wang G; Chen J; Wang JY; Zhou H
    Gastroenterology; 2010 Jan; 138(1):197-209. PubMed ID: 19732776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oximinoarylsulfonamides as potent HIV protease inhibitors.
    Yeung CM; Klein LL; Flentge CA; Randolph JT; Zhao C; Sun M; Dekhtyar T; Stoll VS; Kempf DJ
    Bioorg Med Chem Lett; 2005 May; 15(9):2275-8. PubMed ID: 15837308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis.
    Santos LO; Marinho FA; Altoé EF; Vitório BS; Alves CR; Britto C; Motta MC; Branquinha MH; Santos AL; d'Avila-Levy CM
    PLoS One; 2009; 4(3):e4918. PubMed ID: 19325703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRL-02031, a novel nonpeptidic protease inhibitor (PI) containing a stereochemically defined fused cyclopentanyltetrahydrofuran potent against multi-PI-resistant human immunodeficiency virus type 1 in vitro.
    Koh Y; Das D; Leschenko S; Nakata H; Ogata-Aoki H; Amano M; Nakayama M; Ghosh AK; Mitsuya H
    Antimicrob Agents Chemother; 2009 Mar; 53(3):997-1006. PubMed ID: 18955518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nelfinavir and lopinavir impair Trypanosoma cruzi trypomastigote infection in mammalian host cells and show anti-amastigote activity.
    Sangenito LS; d'Avila-Levy CM; Branquinha MH; Santos ALS
    Int J Antimicrob Agents; 2016 Dec; 48(6):703-711. PubMed ID: 27838277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV aspartic peptidase inhibitors are effective drugs against the trypomastigote form of the human pathogen Trypanosoma cruzi.
    Sangenito LS; Gonçalves DS; Seabra SH; d'Avila-Levy CM; Santos AL; Branquinha MH
    Int J Antimicrob Agents; 2016 Oct; 48(4):440-4. PubMed ID: 27499433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive values of the human immunodeficiency virus phenotype and genotype and of amprenavir and lopinavir inhibitory quotients in heavily pretreated patients on a ritonavir-boosted dual-protease-inhibitor regimen.
    Barrail-Tran A; Morand-Joubert L; Poizat G; Raguin G; Le Tiec C; Clavel F; Dam E; Chêne G; Girard PM; Taburet AM;
    Antimicrob Agents Chemother; 2008 May; 52(5):1642-6. PubMed ID: 18285478
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Palmeira VF; Goulart FRV; Granato MQ; Alviano DS; Alviano CS; Kneipp LF; Santos ALS
    Front Microbiol; 2018; 9():1383. PubMed ID: 30008700
    [No Abstract]   [Full Text] [Related]  

  • 19. Darunavir: a review of its use in the management of HIV infection in adults.
    McKeage K; Perry CM; Keam SJ
    Drugs; 2009; 69(4):477-503. PubMed ID: 19323590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of NO-Hybridization on the Immunomodulatory Properties of the HIV Protease Inhibitors Lopinavir and Ritonavir.
    Fagone P; Mangano K; Quattrocchi C; Cavalli E; Mammana S; Lombardo GA; Pennisi V; Zocca MB; He M; Al-Abed Y; Nicoletti F
    Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):306-15. PubMed ID: 25903922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.